{"gao_id": "GAO-23-104721", "published": "2023-01-17T12:00:00Z", "released": "2023-02-16T07:00:00Z", "summary": "Institutional Review Boards (IRBs) assess the ethics and safety of research studies involving human subjects, such as behavioral studies or clinical trials for new drugs or medical devices. Health and Human Services oversees about 2,300 U.S.-based IRBs through routine or for-cause inspections to assess if they are following federal laws when reviewing research. But few IRBs are inspected. For example, one HHS agency aims to...", "title": "Institutional Review Boards: Actions Needed to Improve Federal Oversight and Examine Effectiveness", "topics": ["Informed consent", "Clinical trials", "Health care", "Compliance oversight", "Human subjects research", "Quality assurance", "Medical research", "Health Care", "Computer network protocols", "Regulatory noncompliance", "Laws and regulations"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-104721", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-23-104721-highlights.pdf"}, {"title": "Full Report (97 pages)", "url": "https://www.gao.gov/assets/gao-23-104721.pdf"}, {"title": "Accessible PDF (104 pages)", "url": "https://www.gao.gov/assets/820/816876.pdf"}]}